Shilpa Medicare surges up by 10 per cent
Shilpa Medicare surges up by 10 per cent

Shilpa Medicare surges up by 10 per cent

Gayathri Udyawar Article rating: 3.0

The stock of Shilpa Medicare spiked up during the early morning session on Wednesday has the company's facilities received EIR from the US drug regulator.

Five stocks with selling interest
Five stocks with selling interest

Five stocks with selling interest

Shital Jibhe Article rating: 5.0

Overall volumes in futures & options currently stand at 63.10 lakh contracts with a turnover of Rs. 5,86,440.62 crore.

Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

Shital Jibhe Article rating: 5.0

Overall volumes in futures & options currently stand at 63.10 lakh contracts with a turnover of Rs. 5,86,440.62 crore.

Index trend and stocks in action July 11, 2018
Index trend and stocks in action July 11, 2018

Index trend and stocks in action July 11, 2018

Karan Dsij Article rating: 5.0

Going forward, we expect Nifty may see the levels of 11,000 and 11,050 acting as immediate resistance areas. However, in case Nifty retreats, supports may come in at the levels of 10,890 and 10,860. Stocks in news: HFCL, KEC International, Reliance Capital, Shalimar Paints, Tata Motors, Axis Bank and Fortis Healthcare. 

Markets may start in the red amid negative cues from Asian peers
Markets may start in the red amid negative cues from Asian peers

Markets may start in the red amid negative cues from Asian peers

Karan Dsij Article rating: 5.0

Stock markets in India are likely to take a breather on the back of sell-off seen in the Asian markets. This was on the backdrop of the Trump administration releasing a list of 10 per cent tariffs on additional US$200 billion of Chinese products, marking a sharp escalation in a trade war between the world’s two largest economies. Nifty 50 index future on the Singapore stock exchange is currently trading with a loss of 25 points at 10,933.   

TCS posts stable results in Q1FY19
TCS posts stable results in Q1FY19

TCS posts stable results in Q1FY19

Rohan Takalkar Article rating: 1.0

The total revenue for the quarter grew by 15 per cent QoQ to Rs 29,368 crore in Q1FY19 as against Rs 25,570 in Q4FY18. The constant currency growth stood at Rs 9.3 per cent YoY and 4.1 per cent QoQ. The BFSI vertical growth accelerated to 3.7 per cent QoQ and 4.1 per cent YoY.

Overnight Digest: Stocks to look out for on July 11
Overnight Digest: Stocks to look out for on July 11

Overnight Digest: Stocks to look out for on July 11

Shohini Nath Article rating: 1.5

The stocks that are likely to witness significant movement on the bourses on Wednesday, July 11, are Tata Consultancy Services, IndusInd Bank , Punjab National Bank , Kridhan Infra Limited and Bank Of Baroda.

Trumps smashing tweet puts brakes on rising pharma stocks
Trumps smashing tweet puts brakes on rising pharma stocks

Trumps smashing tweet puts brakes on rising pharma stocks

Bhagyashree Vivarekar Article rating: 5.0

An abrupt hike in the price of drugs by pharma companies was slammed by US President, Donald Trump in his tweet wherein he specifically commented on Pfizer. Most of the pharma shares listed on Indian exchanges traded in the red during Tuesday’s trading session.

Dynamic asset allocation fund, an efficient way to tackle volatility
Dynamic asset allocation fund, an efficient way to tackle volatility

Dynamic asset allocation fund, an efficient way to tackle volatility

Nikhil Desai Article rating: 5.0

Every mutual fund investor wants to move forward wisely in the current market situation. Each and every investor is trying to minimise their risk exposure and maximise and safeguard returns. For this investors are looking at various options available currently in the mutual fund industry.

RSS
First28942895289628972899290129022903Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR